RT @tdbrothers: It was disappointing to hear an anonymous doctor say "doctors should only prescribe opioids for pain", since the first-line…
It was disappointing to hear an anonymous doctor say "doctors should only prescribe opioids for pain", since the first-line treatment for opioid use disorder is prescribing opioid medications (e.g. methadone, buprenorphine) with many decades of evidence h
@michelletandler @RyanMarino Please consider looking at the Canadian opioid disorder guidelines. They go over why detox treatment is ineffective https://t.co/Q8Y134DEWN
@seadavis7 Management of opioid use disorders: a national clinical practice guideline https://t.co/oDOYOSmp4F
Here's the language from the Canadian OUD guidelines (noting that the Section 56 exemption no longer exists in 2021) https://t.co/Zb58eRSEiS 6/ https://t.co/V2oFtd1hJU
@serotavirus @lockedoutofvenU Here's the language from the Canadian guidelines (noting that the Section 56 exemption no longer exists in 2021) https://t.co/Zb58eRSEiS https://t.co/eZWlA5qgOG
RT @gilliankolla: It would be great to hear from @csam_smca & addiction medicine MDs on the Alberta review panel like @drrobbietee speak to…
RT @gilliankolla: It would be great to hear from @csam_smca & addiction medicine MDs on the Alberta review panel like @drrobbietee speak to…
RT @gilliankolla: It would be great to hear from @csam_smca & addiction medicine MDs on the Alberta review panel like @drrobbietee speak to…
recommending detox is recommending death, which is not good medical advice https://t.co/RYfzAwiM8u
RT @gilliankolla: It would be great to hear from @csam_smca & addiction medicine MDs on the Alberta review panel like @drrobbietee speak to…
RT @sheldonbailey: (1) More misinformation from a physician in Addiction. The report says the committee became concerned with the lack of f…
(1) More misinformation from a physician in Addiction. The report says the committee became concerned with the lack of focus on referrals to detoxification and treatment resources. Where it was suggested that referrals were made,...
RT @gilliankolla: It would be great to hear from @csam_smca & addiction medicine MDs on the Alberta review panel like @drrobbietee speak to…
@drrobbietee
RT @gilliankolla: It would be great to hear from @csam_smca & addiction medicine MDs on the Alberta review panel like @drrobbietee speak to…
RT @tdbrothers: In fact, our national treatment guidelines explicitly advise AGAINST detox alone as a treatment strategy. https://t.co/Zb…
RT @gilliankolla: It would be great to hear from @csam_smca & addiction medicine MDs on the Alberta review panel like @drrobbietee speak to…
RT @gilliankolla: It would be great to hear from @csam_smca & addiction medicine MDs on the Alberta review panel like @drrobbietee speak to…
RT @gilliankolla: It would be great to hear from @csam_smca & addiction medicine MDs on the Alberta review panel like @drrobbietee speak to…
It would be great to hear from @csam_smca & addiction medicine MDs on the Alberta review panel like @drrobbietee speak to this point. The lack of consistency btwn evidence base addiction treatment guidelines and the findings of the Alberta review are g
RT @tdbrothers: In fact, our national treatment guidelines explicitly advise AGAINST detox alone as a treatment strategy. https://t.co/Zb…
this IS vErY ǝ⅁uɐɹʇS dr tommy, for a government review to recommend a process (detox) when medical guidelines say "don't, b/c death". doctors give their authority to the conclusions of 194pp of fear-based anecdotal misinformation. is that a doctor, really
RT @tdbrothers: In fact, our national treatment guidelines explicitly advise AGAINST detox alone as a treatment strategy. https://t.co/Zb…
RT @tdbrothers: In fact, our national treatment guidelines explicitly advise AGAINST detox alone as a treatment strategy. https://t.co/Zb…
In fact, our national treatment guidelines explicitly advise AGAINST detox alone as a treatment strategy. https://t.co/Zb58eRSEiS Very strange that detox is prioritized in this document co-authored by addiction physicians. 4/ https://t.co/IzemES5ZRx
@StefanKertesz I suggest looking at the references cited for the outcomes you are looking for in a comprehensive clinical practice guideline such as this: https://t.co/TbQKqmtGmf
Agree, excellent resource for Opioid Use Disorder:
@csam_smca @vyapada @daveewlucas @RyanMarino @ColleenDockerty @drlhayer @_Jessica______M @carole_sinclair @LanceShaver @phil_luttazi @EricMoffitt6 @Jonathanstewar1 @MHPoison1 So much Canadian expertise went into this one. I recommended it to all the resid
@yauser @medmyths And, um, there’s already a guideline https://t.co/Bfz34eVIsa
@RNickGorton Thanks! It's amazing how many of our colleagues have NO IDEA about evidence-based treatment for SUD Still lots of MDs referring to "detox" as treatment for OUD, and curious raised eyebrows when I tell them that detox alone kills people (@Keit
Management of opioid use disorders: a national clinical practice guideline.Canada - PubMed - NCBI https://t.co/LYvYgBGJoK
@aribindi @Atul_Gawande @DrSarahWakeman @ml_barnett @NEJM Find here our Canadian guidelines that recommend against withdrawal management only. In BC, medications are now covered for everyone on social assistance and those making less than $42k/yr. though,
RT @TripPrimaryCare: New2Trip: Management of opioid use disorders: national clinical practice guideline https://t.co/VgzjIz48Kk
New2Trip: Management of opioid use disorders: national clinical practice guideline https://t.co/VgzjIz48Kk
New2Trip: Management of opioid use disorders: national clinical practice guideline https://t.co/yfUOcKcEXK
New2Trip: Management of opioid use disorders: national clinical practice guideline https://t.co/VgzjIz48Kk
New2Trip: Management of opioid use disorders: national clinical practice guideline https://t.co/VgzjIz48Kk
New2Trip: Management of opioid use disorders: national clinical practice guideline https://t.co/yfUOcKcEXK
New2Trip: Management of opioid use disorders: national clinical practice guideline https://t.co/VgzjIz48Kk
New2Trip: Management of opioid use disorders: national clinical practice guideline https://t.co/VgzjIz48Kk
New2Trip: Management of opioid use disorders: national clinical practice guideline https://t.co/yfUOcKcEXK
"Новые канадские рекомендации задают оптимальные стратегии лечения опиоидной зависимости, включая рекомендацию использования в качестве предпочтительной первой линии терапии опиоидных агонистов бупренорфина-налоксона. Рекомендации... https://t.co/Mt16yB5o8
New2Trip: Management of opioid use disorders: national clinical practice guideline https://t.co/VgzjIz48Kk
New2Trip: Management of opioid use disorders: national clinical practice guideline https://t.co/VgzjIz48Kk
New2Trip: Management of opioid use disorders: national clinical practice guideline https://t.co/yfUOcKcEXK
RT @SandyDongMD: Required reading for all health care providers. https://t.co/7Msd8eyPsZ
New2Trip: Management of opioid use disorders: national clinical practice guideline https://t.co/VgzjIz48Kk
RT @SandyDongMD: Required reading for all health care providers. https://t.co/7Msd8eyPsZ
RT @SandyDongMD: Required reading for all health care providers. https://t.co/7Msd8eyPsZ
Required reading for all health care providers. https://t.co/7Msd8eyPsZ
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
Morning PLC rounds on #Anesthesia management of the patient on #Suboxone @UCalgaryMed #meded #pain @AHS_YYCZone https://t.co/x7wSE38TKi
New2Trip: Management of opioid use disorders: national clinical practice guideline https://t.co/sJrFVK6fxO
Management of opioid use disorders: a national clinical practice guideline https://t.co/EcUEsqE5hZ
New2Trip: Management of opioid use disorders: national clinical practice guideline https://t.co/kStZhJ2oGO
New2Trip: Management of opioid use disorders: national clinical practice guideline https://t.co/sJrFVK6fxO
Some great, evidence-based guidelines from our friends to the north @cmaj https://t.co/cVHzPPnWZS #hmstox18 https://t.co/qDKAkNQlhS
RT @HIV_Insight: Management of #opioid use disorders: A national clinical practice guideline https://t.co/WUWZhCOY0T HT @UMontreal #opioid…
Management of #opioid use disorders: A national clinical practice guideline https://t.co/WUWZhCOY0T HT @UMontreal #opioids #SUD #PWUD #PWID #IDU https://t.co/cqVa7qpvVh
Management of #opioid use disorders: A national clinical practice guideline https://t.co/u3vyW8aG0P HT @UMontreal #opioids #SUD #PWUD #PWID #IDU https://t.co/tQsZW9KbQW
Management of #opioid use disorders: A national clinical practice guideline https://t.co/YBaLh6qDa3 HT @UMontreal #opioids #SUD #PWUD #PWID #IDU https://t.co/xwCd757TZu
New2Trip: Management of opioid use disorders: national clinical practice guideline https://t.co/sJrFVK6fxO
New2Trip: Management of opioid use disorders: national clinical practice guideline https://t.co/kStZhJ2oGO
New2Trip: Management of opioid use disorders: national clinical practice guideline https://t.co/sJrFVKnQpm
New2Trip: Management of opioid use disorders: national clinical practice guideline https://t.co/sJrFVK6fxO
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
New2Trip: Management of opioid use disorders: national clinical practice guideline https://t.co/kStZhJjZym
New2Trip: Management of opioid use disorders: national clinical practice guideline https://t.co/sJrFVK6fxO
New2Trip: Management of opioid use disorders: national clinical practice guideline https://t.co/sJrFVK6fxO
RT @TripPrimaryCare: New2Trip: Management of opioid use disorders: national clinical practice guideline https://t.co/sJrFVK6fxO
RT @TripPrimaryCare: New2Trip: Management of opioid use disorders: national clinical practice guideline https://t.co/sJrFVK6fxO
New2Trip: Management of opioid use disorders: national clinical practice guideline https://t.co/sJrFVK6fxO
New2Trip: Management of opioid use disorders: national clinical practice guideline https://t.co/kStZhJ2oGO
Management of #opioid use disorders: A national clinical practice guideline https://t.co/C1dc0pJIyu HT @UMontreal #opioids #SUD #PWUD #PWID #IDU https://t.co/JEvZQhGKvP
Management of #opioid use disorders: A national clinical practice guideline https://t.co/u3vyW8aG0P HT @UMontreal #opioids #SUD #PWUD #PWID #IDU https://t.co/HP2sZpySPJ
Management of #opioid use disorders: A national clinical practice guideline https://t.co/WUWZhCOY0T HT @UMontreal #opioids #SUD #PWUD #PWID #IDU https://t.co/eh7HQtCS5C
Management of #opioid use disorders: A national clinical practice guideline https://t.co/YBaLh6qDa3 HT @UMontreal #opioids #SUD #PWUD #PWID #IDU https://t.co/6er1Ds8ttk
New2Trip: Management of opioid use disorders: national clinical practice guideline https://t.co/sJrFVKnQpm
Management of opioid use disorders: a national clinical practice guideline https://t.co/cL4m8pXeai #opioids
New2Trip: Management of opioid use disorders: national clinical practice guideline https://t.co/sJrFVK6fxO
RT @hakique: If you treat opioid use disorder, here's the world's best guideline on how you should. If you don't, start. https://t.co/kmb7…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @theresaboyle: Management of opioid use disorders: a national clinical practice guideline - CMAJ https://t.co/q7SfoJPuyg via @nuzzel tha…
RT @hakique: If you treat opioid use disorder, here's the world's best guideline on how you should. If you don't, start. https://t.co/kmb7…
RT @DavidJuurlink: This is big. New clinical practice guideline on management of opioid use disorders. https://t.co/DcES6D7E09 open-access…
RT @theresaboyle: Management of opioid use disorders: a national clinical practice guideline - CMAJ https://t.co/q7SfoJPuyg via @nuzzel tha…
RT @CMAJ: New guideline for managing opioid use disorders recommends buprenorphine–naloxone as the preferred first-line treatment, and warn…
Canadian clinical practice guidelines recommend clinicians use buprenorphine–naloxone as first-line opioid agonist treatment when possible & avoid withdrawal treatment alone due to higher rates of relapse and overdose deaths. Via @CMAJ https://t.co/Nq
RT @DavidJuurlink: Front and centre: "Initiate opioid agonist treatment (with buprenorphine–naloxone whenever feasible), to reduce the ris…
RT @DrSarahWakeman: Fantastic, science-based guidelines on how to treat opioid use disorder from @CMAJ https://t.co/qm7udtjPjZ https://t.co…
Manejo de los trastornos por uso de opioides: nueva guía de práctica clínica, de libre acceso en @CMAJ https://t.co/zi3iN6yNPP